Hsbc Holdings PLC Purchases New Shares in Tempus AI, Inc. $TEM

Hsbc Holdings PLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 94,732 shares of the company's stock, valued at approximately $4,423,000. Hsbc Holdings PLC owned about 0.06% of Tempus AI as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Cliffwater LLC bought a new position in shares of Tempus AI in the first quarter valued at about $667,000. Cladis Investment Advisory LLC bought a new position in shares of Tempus AI in the first quarter valued at about $227,000. Partners Group Holding AG bought a new position in shares of Tempus AI in the first quarter valued at about $1,949,000. Tyler Stone Wealth Management bought a new position in shares of Tempus AI in the first quarter valued at about $386,000. Finally, United Capital Management of KS Inc. bought a new position in shares of Tempus AI in the first quarter valued at about $482,000. 24.22% of the stock is owned by institutional investors.

Insider Buying and Selling

In other news, CFO James William Rogers sold 7,528 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares of the company's stock, valued at $10,337,009.45. This represents a 5.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Eric P. Lefkofsky sold 17,458 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,239.70. Following the completion of the sale, the chief executive officer directly owned 2,020,042 shares of the company's stock, valued at approximately $150,796,135.30. This trade represents a 0.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 776,451 shares of company stock worth $53,022,688 over the last quarter. Insiders own 26.27% of the company's stock.

Tempus AI Stock Performance

Shares of TEM stock opened at $75.90 on Tuesday. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The stock has a market cap of $13.19 billion, a PE ratio of -63.78 and a beta of 4.98. The stock has a 50-day moving average of $63.86 and a 200-day moving average of $59.15. Tempus AI, Inc. has a one year low of $31.36 and a one year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI's revenue was up 89.5% on a year-over-year basis. During the same period in the prior year, the business posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

TEM has been the subject of a number of research analyst reports. Morgan Stanley lifted their price target on Tempus AI from $65.00 to $68.00 and gave the company an "overweight" rating in a report on Tuesday, August 12th. Needham & Company LLC reissued a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a report on Friday, August 8th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Bank of America boosted their price objective on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a report on Wednesday, June 25th. Finally, Guggenheim boosted their price objective on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Tempus AI currently has an average rating of "Moderate Buy" and an average price target of $67.64.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.